"" HRT Financial LP, a director and 10% owner of Profusa Inc. (NASDAQ:PFSA), sold a notable block of the company's common stock on August 17, 2026. The transaction involved the disposition of 18,395 shares, resulting in a total value of $109,266.
The timing of the sale is notable given the stock's extreme volatility, with shares currently trading at $12.35 and posting a remarkable 612% return over the past week.
Profusa faces significant financial headwinds, with InvestingPro assigning a "WEAK" overall financial health score and noting the company is quickly burning through cash. Following this sale, HRT Financial LP directly holds 0 shares of Profusa Inc. common stock.
In other recent news, Profusa Inc. announced the approval of several significant proposals at its annual shareholder meeting, including the planned acquisition of the PanOmics multi-omics diagnostics platform from BioInsights LLC. The company also filed an amendment to implement a 1-for-25 reverse stock split, which will take effect on July 7, 2026, as part of efforts to maintain compliance with Nasdaq listing requirements.
